Homoeopathic treatment of Psoriasis
- Conditions
- Health Condition 1: L40- Psoriasis
- Registration Number
- CTRI/2018/11/016481
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Cases presenting with plaque type psoriasis i.e., well-defined, erythematous, scaly lesion which becomes slivery on attempt to scrape.
1.Cases with guttate psoriasis & pustular psoriasis.
2.Cases with psoriatic arthritis
3.Not on any treatment for psoriasis over the last 6 months
4.Patents willing to refrain from using any of the following treatments during the study period:
oSystemic treatments for psoriasis (e.g., PUVA, cyclosporine, corticosteroids, methotrexate, oral retinoids, MMF, thioguanine, hydroxyurea, sirolimus, azathioprine, 6-MP, etanercept) and immunosuppressive medications for any indication other than psoriasis.
oTreatment with UVB phototherapy and all other topical treatments for psoriasis (e.g., topical corticosteroids, calcipotriene, tazarotene, anthralin, tar). Tanning booths or non-prescription UV light sources are not to be used.
•Evidence of skin conditions (eg, eczema) other than psoriasis that would interfere with evaluations of the effect of study medication on psoriasis
•Be a candidate for systemic immune-suppressive therapy, in the opinion of the investigator, where in the patient has generalized psoriasis with significant functional impairment and high levels of distress.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method